Val-HeFT

Val-HeFT

Valsartan heart failure trial Cardiology A multinational M&M study investigating valsartan use with standard therapy–eg, ACE inhibitors, in Pts with previously treated and untreated CHF. See Valsartan.
Mentioned in ?
References in periodicals archive ?
4] Nonstandard abbreviations: hs-cTnT, highly sensitive cardiac troponin T (assay); hs-cTnI, highly sensitive cardiac troponin I (assay); MI, myocardial infarction; hs-CRP, high-sensitivity C-reactive protein; Val-HeFT, Valsartan Heart Failure Trial; PEACE, Prevention of Events with Angiotensin Converting Enzyme Inhibition; NT-proBNP, N-terminal pro-B-type natriuretic peptide; ED, emergency department.
Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial).
The large outcome trials VALUE, VALIANT, and Val-HEFT demonstrated effective blood pressure lowering and cardioprotective benefits of Diovan in a range of different patient types(10,11,12).
Captopril Val-HeFT (55) (2001) NYHA Class II-IV (5010) Valsartan vs.
However, patients in the Val-HeFT trial who took ARBs with an ACE inhibitor and a [beta]-blocker had worse outcomes.
The most common side effects in Val-HeFT were dizziness and hypotension.
The Val-Heft study reported similar results in terms of additive prognostic information by using hscTnT measurement and a natriuretic peptide (14).
Completed Diovan trials include VALUE in high blood pressure patients at high risk for cardiovascular events, VALIANT in post-heart attack patients and Val-HeFT in heart failure patients.
Val-HeFT demonstrated that Diovan significantly reduced combined all-cause mortality and morbidity in patients with heart failure also taking usual therapy.
Recently completed Diovan trials include VALUE in high blood pressure patients; VALIANT in post-heart attack patients; and Val-HeFT in heart failure patients.
First came Val-HeFT, a study showing that valsartan didn't reduce mortality, and which suggested that combining the ARB with an ACE inhibitor and a [beta]-blocker might actually be harmful.